Modeling of the inhibition of retroviral integrases by styrylquinoline derivatives

Journal of Medicinal Chemistry

Volumn 43, Issue 10, 2000, Pages 1949-1957

  Ouali, Mohammed ^a   Laboulais, Cyril ^a   Leh, Hervé ^a   Gill, David ^a   Desmaële, Didier ^b   Mekouar, Khalid ^b   Zouhiri, Fatima ^b   D'Angelo, Jean ^b   Auclair, Christian ^a   Mouscadet, Jean François ^a   Le Bret, Marc ^a  

^a CNRS   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INTEGRASE; QUINOLINE DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; CRYSTALLOGRAPHY; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; QUANTUM CHEMISTRY; SITE DIRECTED MUTAGENESIS; VIRUS REPLICATION;

EID: 0034120379     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9911581     Document Type: Article

References (47)

1. Ho, D. D.; Neumann, A. U.; Perelson, A. S.; Chen, W.; Leonard, J. M.; Markowitz, M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373, 123-126.
2. Zhang, L.; Ramratnam, B.; Tenner-Racz, K.; He, Y.; Vesanen, M.; Lewin, S.; Talal, A.; Racz, P.; Perelson, A.; Korber, B.; Markowitw, M.; Ho, D. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N. Engl. J. Med. 1999, 340, 1605-1613.
3. Furtado, M.; Callaway, D.; Phair, J.; Kunstman, K.; Stanton, J.; Macken, C.; Perelson, A.; Wolinsky, S. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N. Engl. J. Med. 1999, 340, 1614-1622.
4. De Clercq, E. Toward improved anti-HIV chemotherapy: Therapeutic strategies for intervention with HIV infections. J. Med. Chem. 1995, 38, 8, 2491-2517.
5. Pommier, Y.; Neamati, N. Inhibitors of human immunodeficiency virus integrase. Adv. Virus Res. 1999, 52, 427-58.
6. Lafemina, R. L.; Schneider, C. L.; Robbins, H. L.; Callahan, P. L.; Legrow, K.; Roth, E.; Schleif, W. A.; Emini, E. A. Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. J. Virol. 1992, 66, 7414-7419.
7. Engelman, A.; Mizuuchi, K.; Craigie, R. HIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transfer. Cell 1991, 67, 1211-1221.
8. Brown, P. O. Integration of retroviral DNA. Curr. Top. Microbiol. Immunol. 1990, 157, 19-48.
9. Katz, R. A.; Skalka, A. M. The retroviral enzymes. Annu. Rev. Biochem. 1994, 63, 133-173.
10. Bushman, F. D.; Craigie, R. Activities of human immunodeficiency virus (HIV) integration protein in vitro: Specific cleavage and integration of HIV DNA. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 1339-1343.
11. Chow, S. A.; Vincent, K. A.; Ellison, V.; Brown, P. O. Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science 1992, 255, 723-726.
12. Dyda, F.; Hickman, A. B.; Jenkins, T.; Engelman, A.; Craigie, R.; Davies, D. Crystal structure of the catalytic domain of HIV-1 integrase: Similarity to other polynucleotidyl transferases. Science 1994, 266, 1981-1986.
13. Maignan, S.; Guilloteau, J. P.; Zhou-Liu, Q.; Clément-Mella, C.; Mikol, V. Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: High level of similarity of the active site with other viral integrases. J. Mol. Biol. 1998, 282, 359-368.
14. Goldgur, Y.; Dyda, F.; Hickman, A.; Jenkins, T.; Craigie, R.; Davies, D. Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 9150-9154.
15. Cowan, J. A. Metal activation of enzymes in nucleic acid biochemistry. Chem. Rev. 1998, 98, 1067-1087.
16. Mekouar, K; Mouscadet, J. F.; Desmaële, D.; Subra, F.; Leh, H.; Savouré, D.; Auclair, C.; d'Angelo, J. Styrylquinoline derivatives: a new class of potent HFV-1 integrase inhibitors that block HIV-1 replication in CEM cells. J. Med. Chem. 1998, 41, 2846-2857.
17. Bujacz, G.; Jaskolki, M.; Alexandratos, J.; Wlodawer, A.; Merkel, G.; Katz, R. A.; Skalka, A. M. High-resolution structure of the catalytic domain of avian sarcoma virus integrase. J. Mol. Biol. 1995, 253, 333-346.
18. Le Bret, M.; Gabarro-Arpa, J.; Gilbert, J. C.; Lemaréchal, C. MORCAD, an object-oriented molecular modelling package running on IBM RS/6000 and SGI 4Dxxx workstations. J. Chim. Phys. 1991, 88, 2489-2496.
19. Cornell, W. D.; Cieplak, P.; Bayly, C. I.; Goulg, I. R.; Merz, K. M.; Ferguson, D. M.; Spellmeyer, D. C.; Fox, T.; Caldwell, J. W.; Kollman, P. A. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc. 1995, 117, 5179-5197.
20. Shoichet B. K. Docking ligands to proteins. In Protein Structure Prediction; Edited by Sternberg, M. J. The Practical Approach Series; Rickwood, D., Hames, B., Eds.; 1996; Chapter 11, pp 263-290.
21. Katchalski-Katzir, E.; Shariv, I.; Eisenstein, M.; Friesem, A. A.; Aflalo, C.; Vakser, I. A. Molecular surface recognition: determination of geometric fit between proteins and their ligands by correlation techniques. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 2195-2199.
22. Friedman, J. Fourier-filtered van der Waals contact surfaces: accurate ligand shapes from protein structures. Protein Eng. 1997, 10, 851-863.
23. Gabb, H.; Jackson, R.; Sternberg, M. Modelling protein docking using shape complementarity, electrostatics and biochemical information. J. Mol. Biol. 1997, 272, 106-120.
24. Rogers, N.; Sternberg, M. Electrostatic interactions in globular proteins. Different dielectric models applied to the packing of alpha-helices. J. Mol, Biol. 1984, 174, 527-542.
25. Aqvist, J. Ion-water interaction potentials derived from free energy perturbation simulations. J. Phys. Chem. 1990, 94, 8021-8024.
26. Lavery, R.; Sklenar, H.; Zakrzwska, K.; Pullman, B. The flexibility of the nucleic acids: (II). The calculation of internal energy and applications to mononucleotide repeat DNA. J. Biomol. Struct. Dyn. 1986, 3, 989-1014.
27. Frisch, M. J.; Trucks, G. W.; Schlegel H. B.; Gill, P. M. W.; Johnson, B. G.; Robb, M. A.; Cheeseman, J. R.; Keith, T.; Petersson, G. A.; Montgomery, J. A.; Raghavachari, K.; Al-Laham, M. A,; Zakrzewski, V. G.; Ortiz, J. V.; Foresman, J. B.; Cioslowski, J.; Stefanov, B. B.; Nanayakkara, A.; Challacombe, M.; Peng, C. Y.; Ayala, P. Y.; Cher, W.; Wong, M. W.; Andres, J. L.; Replogle, E. S.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Binkley, J. S.; Defrees, D. J.; Baker, J.; Stewart, J. P.; Head-Gordon, M.; Gonzalez, C.; Pople, J. A. Gaussian 94, Revision E.2; Gaussian Inc.: Pittsburgh, PA, 1995.
28. Besler, B. H.; Merz, K. M.; Kollman, P. A. Atomic charges derived from semiempirical methods. J. Comput, Chem. 1990, 11, 431-439.
29. Boys, S. F.; Bernardi, F. The calculation of small molecular interactions by the differences of separate total energies. Some procedures with reduced errors. Mol. Phys. 1970, 79, 553-566.
30. Jenkins, T. M.; Engelman, A.; Ghirlando, R.; Craigie, R. Asoluble active mutant of HIV-1 integrase: involvement of both the core and carboxyl-terminal domains in multimerization. J. Biol. Chem. 1996, 271, 7712-7718.
31. Chow, S. A.; Brown, P. O. Substrate features important for recognition and catalysis by human immunodefficiency virus type 1 integrase identified by using novel DNA substrates. J. Virol. 1994, 68, 3896-3907.
32. Timberlake, C. Potentiometric and polarographic study of copper catechol complexes. J. Chem. Soc. 1957, 997, 4987-4993.
33. Branch, G. E. K.; Yabroff, D. L. The anomalous strength of salicylic acid. J. Am. Chem. Soc. 1934, 56, 2568-2570.
34. N. A. Lange Ed. In Handbook of Chemistry, 10th ed.; McGraw-Hill Book Company: New York, 1967.
35. Bardez, E.; Devol, I.; Larrey, B.; Valeur, B. Excited-state processes in 8-hydroxyquinoline: Photoinduced tautomerization and solvation effects. J. Phys. Chem. B 1997, 101, 7786-7793.
36. Albert, A.; Phillips, J. N. Ionization constants of heterocyclic substances. Part II: Hydroxy derivatives of nitrogenous six-membered ring compounds. J. Chem. Soc. 1956, 264, 1294-1304.
37. Lahmani, F.; Zehnacker-Rentien, A. Effect of substitution on the photoinduced intramolecular proton transfer in salicylic acid. J. Phys. Chem. A 1997, 101, 6141-6147.
38. Sobolewski, A.; Domcke, W. Ab initio study study of excitedstate intramolecular proton dislocation in salicylic acid. Chem. Phys. 1998, 232, 257-265.
39. Dougherty, D. A. Cation-π interactions in chemistry and biology: A new view of benzene, Phe, Tyr, and Trp. Science 1996, 271, 163-168.
40. Ma, J. C.; Dougherty, D. A. The cation-π interaction. Chem. Rev. 1997, 97, 1303-1324.
41. Nicklaus, M. C.; Neamati, N.; Hong, H.; Mazumder, A.; Sunder, S.; Chen, J.; Milne, G.; Pommier Y. HIV-1 integrase pharmacophore: Discovery of inhibitors through three-dimensional database searching. J. Med. Chem. 1997, 40, 920-929.
42. Goldgur, Y.; Craigie, R.; Cohen, G.; Fujiwara, T.; Yoshinaga, T.; Fujishita, T.; Sugimoto, H.; Endo, T.; Murai, H.; Davies, D. Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 13040-13043.
43. Lubkowski, J.; Yang, F.; Alexandratos, J.; Wlodawer, A.; Zhao, H.; Burke, T.; Neamati, N.; Pommier, Y.; Merkel, G.; Skalka, A. M. Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitor. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 4831-4836.
44. Robinson, E.; Cordeiro, M.; Abdel-Malek, S.; Jia, Q.; Chow, S.; Reinecke, M.; Mitchell, W. Dicaffeoylquinnic acid inhibitors of human immunodefficiency virus integrase: Inhibition of the core catalytic domain of human immunodeficiency virus integrase. Mol. Pharmacol. 1996, 50, 846-855.
45. King, P.; Robinson, E. Resistance to the anti-human immunodefficiency virus type 1 compound L-chicoric acid results from a single mutation at amino acid 140 of integrase. J. Virol. 1998, 72, 8420-8424.
46. Zouhiri, F.; Mouscadet, J. F.; Mekouar, Kh.; Desmaele, D.; Savouré, D., Leh, H.; Subra. F.; Le Bret, M.; Auclair, C.; d'Angelo, J. Structure - activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1-integrase and replication of HIV-1 in cell culture. J. Med. Chem. In press.
47. Ouali, M.; Laboulais, C.; Leh, H.; Gill, D.; Xhuvani, E.; Zouhiri, F.; Desmaële, D.; d'Angelo, J.; Auclair, C.; Mouscadet, J. F.; Le Bret, M. Tautomers of styrylquinoline derivatives containing a methoxy substituent: Computation of their population in aqueous solution and their interaction with RSV integrase catalytic core. Acta Biochim. Polonica 2000, 47, 11-22.